Table 3.
Relationship Between Disease Severity and Efficacy Evaluation in Each Treatment Times Group
Treatment Week | Mild Improvement | Moderate Improvement | Marked Improvement | P value (Wilcoxon Test) | |
---|---|---|---|---|---|
≥12 week number | Severe | 0 | 2 (15.4) | 0 | 0.272 |
Moderate | 6 (46.2) | 4 (30.8) | 1 (7.7) | ||
12 > week number ≥8 | Severe | 3 (9.7) | 1 (3.2) | 6 (19.4) | 0.111 |
Moderate | 9 (29.0) | 8 (25.8) | 4 (12.9) | ||
8 > week number ≥4 | Severe | 0 | 0 | 1 (3.6) | 0.088 |
Moderate | 12 (42.9) | 13(46.4) | 2 (7.1) | ||
4> week number ≥1 | Severe | 1 (9.1) | 0 | 0 | 0.306 |
Moderate | 4 (36.4) | 4 (36.4) | 2 (18.2) |